Search

Your search keyword '"Medicine, Experimental"' showing total 9,674 results

Search Constraints

Start Over You searched for: Descriptor "Medicine, Experimental" Remove constraint Descriptor: "Medicine, Experimental" Publisher comtex news network, inc. Remove constraint Publisher: comtex news network, inc.
9,674 results on '"Medicine, Experimental"'

Search Results

1. Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference

2. Novartis ribociclib (Kisqali(R)) recognized as Category 1 preferred breast cancer adjuvant treatment by NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(R))

3. Australian study discovers genetic link between brain volume, disorders

4. BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

5. Australian medical research body recommends cutting acceptable limits of PFAS chemicals in water

6. Bright Peak Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of BPT567, a First-in-Class Bifunctional PD1-IL18 Immunoconjugate

8. Inventiva announces financing of up to EUR348 million to advance the NATiV3 Phase 3 MASH study

9. The Wistar Institute and University of Pennsylvania Scientists Identify Potential Target Gene within Certain HIV Reservoir Cells

10. Theriva(TM) Biologics Announces Positive Outcome of Data and Safety Monitoring Committee (DSMC) Review in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

12. U.S. researchers discover gene responsible for rare, inherited eye disease

13. Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome

14. Type 1 diabetes patient functionally cured via chemically induced stem cell-islets

15. Fewer than half U.S. jails provide medications for opioid use disorder: study

16. Former U.S. CDC Director joins Board of Swiss health technology company: ARTIDIS announces board appointment of Dr. Julie Gerberding, President and CEO of the U.S. Foundation for the National Institutes of Health (FNIH)

17. Press Release: Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU

18. Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma

20. Acrivon Therapeutics to Present at the Cantor Global Healthcare Conference

21. Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers

22. Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers

23. CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY(R), in a Phase 1 Study in Patients with Solid Tumors

24. Psyence Biomed Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care

25. Akero Therapeutics Announces First Patient Dosed in Phase 3 SYNCHRONY Outcomes Study of Efruxifermin in Patients with Compensated Cirrhosis Due to MASH

26. Acrivon Therapeutics to Host Virtual Investor Event to Review Positive Phase 2 Clinical Data of ACR-368 Presented at ESMO and Pipeline Progress, Including Clinical Candidate ACR-2316

27. Splash Clinical Announces Partnership with Cambridge Cognition

28. New Clinical Data Validates Vor Bio's Approach of Using Shielded Transplants to Deliver Targeted Therapies

29. RadNet's DeepHealth and HOPPR Forge Partnership to Advance AI in Healthcare

30. Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte(R) Liquid

31. Fitness World Canada Partners with Augie's Quest in the Mission to Cure ALS

32. Avalyn Announces Initiation of its Global Phase 2b MIST Study of AP01 Inhaled Pirfenidone for Progressive Pulmonary Fibrosis

33. Australian researchers make breakthrough in creating lab-grown blood stem cells

36. Children's Hospital at London Health Sciences Centre and Shriners Hospitals for Children Canada announce groundbreaking affiliation agreement

37. Scilex Holding Company Announces FDA Final Approval to Precision Dosing for GLOPERBA(R) Label

38. Foundation for Sarcoidosis Research Expands Scientific Advisory Board with 14 New Experts to Enhance Sarcoidosis Research and Patient Care

39. Novartis twice-yearly* Leqvio(R) demonstrated clinically meaningful, statistically significant LDL-C lowering as a monotherapy in patients at low or moderate ASCVD risk

41. Avance Clinical Wins 2024 Frost & Sullivan Award for Global Biotech CRO Excellence

42. Mental disorder symptoms are not random: study

43. CenExel Announces Appointment of Patrick McLaughlin as Chief Operating Officer

44. Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery

45. Microbiotica's Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies

46. MDA Kicks Off Muscular Dystrophy Awareness Month in September with '30 Days of Strength' Campaign with Hundreds of Events to Advance Research and Care for the Neuromuscular Disease Community

47. KFSHRC Empowers Future Healthcare Leaders with Innovative Research Programs

48. PharmAla Launches MDMA Clinical Trial Tool for Researchers

49. CervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies

50. Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacimab, in Patients with Obesity

Catalog

Books, media, physical & digital resources